AMPLY Discovery Limited

Investor: Keeps Biomed

AMPLY Discovery Limited, a UK-based AI-driven drug discovery company, has announced a strategic investment from Keeps Biomed, a subsidiary of South Korean specialist biotech company Keeps Biopharma. Summary of transaction details: Value: Not Disclosed Sector: Healthcare & Biotech Advisor: Not Disclosed Key Entities: AMPLY Discovery Limited, Keeps Biomed Location: UK, South Korea Note: This investment is expected to drive future collaboration opportunities in oncology and highlights the growing importance of strategic partnerships in the biotech industry.